Symbiosis Pharmaceutical Services

About:

A leading GMP contract manufacturer of novel injectable pharmaceuticals for use in clinical trials.

Website: http://www.symbiosis-pharma.com

Twitter/X: SymbiosisPharma

Top Investors: Innovate UK

Description:

Symbiosis Pharmaceutical Services was established in 2011 in response to increasing global demand for niche, sterile manufacturing specialists that could satisfy product supply needs for clinical trials. We created our purpose-built facility in Stirling, Scotland, specifically designed with biologic and small molecule production capabilities in mind to support biotech and speciality pharmaceutical companies worldwide that require small-scale injectable products. Differing from most CMOs, from the day our operations commenced we offered rapid access to manufacturing slots and quick release of drug products to ensure tight timelines are successfully met. Naturally, this has been a real hit with our clients.

Total Funding Amount:

1.5M GBP

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

contact(AT)symbiosis-pharma.com

Founders:

Colin MacKay

Number of Employees:

101-250

Last Funding Date:

2019-12-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai